Pitch deck
Transcend's pitch deck
The deck, and the 4 rounds we watched Transcend raise afterwards, with the investors each report named.
Transcend Medical focuses on the research and development of novel devices for the treatment of glaucoma.
Read the deckFree account. The deck belongs to Transcend, so reading it needs one; everything on this page is public.
What is in it
The deck, slide by slide
Each slide by what it argues. 15 slides against a median of 13 across the 1,712 decks we hold.
- 1Cover
- 2Vision
- 3Problem
- 4Product
- 5Market
- 6
- 7Product
- 8Product
- 9Product
- 10Validation
- 11Go to market
- 12Market
- 13Product
- 14Problem
- 15Team
CoverVisionProblemProductMarketValidationGo to marketTeam
What happened next
$64M across 4 rounds
- Dec 2025
- May 2024
- Jul 2023
- Apr 2019
What they told the regulator
Transcend filed 2 Form Ds with the SEC
The company reporting its own raise, rather than a journalist reporting it.
1 / 15The deck itself
Read Transcend's full pitch deck
All 15 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.
Read the deck →Free account. The deck belongs to Transcend.
Investors who claim them
Firms listing Transcend on their own portfolio page: the firm's own account rather than a round we watched. Weaker than an announcement, much stronger than a list somebody sold us.
EnFiVC firm
MagellanVenture studioMore decks
ReplicatedCloud infrastructure1 / 15$57M raised after
AthennianCloud infrastructure1 / 6$34M raised after
SpaceXAI1 / 15$42B raised afterBrowse all 1,712 decks. We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, tell us and it goes.